MPMichael S. Perkinton

Michael S. Perkinton

*This is an algorithmically generated author record based on publicly available information.

Michael S. Perkinton has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    cGAS-STING signalling regulates microglial chemotaxis in genome instability

    by Emily J Talbot, Lisha Joshi, Peter Thornton, Mahya Dezfouli, Kalliopi Tsafou, Michael Perkinton, Svetlana V Khoronenkova

    Defective DNA damage signalling and repair is a hallmark of age-related and genetic neurodegenerative disease. One mechanism implicated in disease progression is DNA damage-driven neuroinflammation, which is largely mediated by tissue-resident immune cells, microglia. Here, we utilise human microglia-like cell models of persistent DNA damage and ATM kinase deficiency to investigate how genome instability shapes microglial function. We demonstrate that upon DNA damage the cytosolic DNA sensing cGAS-STING axis drives chronic inflammation and a robust chemokine response, exemplified by production of CCL5 and CXCL10. Transcriptomic analyses revealed that cell migratory pathways were highly enriched upon IFN-β treatment of human iPSC-derived microglia, indicating that the chemokine response to DNA damage mirrors type I interferon signalling. Furthermore, we find that STING deletion leads to a defect in microglial chemotaxis under basal conditions and upon ATM kinase loss. Overall, this work provides mechanistic insights into cGAS-STING-dependent neuroinflammatory mechanisms and consequences of genome instability in the central nervous system.


  • Open Access

    Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo

    by Darren J. Schofield, Lorraine Irving, Laura Calo, Anna Bogstedt, Gareth Rees, Annalisa Nuccitelli, Rajesh Narwal, Marcella Petrone, Jennifer Roberts, Lee Brown, et al.


  • Open Access

    Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy

    by Arthur Lionnet, Matthew A. Wade, Anne-Gaëlle Corbillé, Alice Prigent, Sébastien Paillusson, Maddalena Tasselli, Jacques Gonzales, Emilie Durieu, Malvyne Rolli-Derkinderen, Emmanuel Coron, et al.

    Tau is normally a highly soluble phosphoprotein found predominantly in neurons. Six different isoforms of tau are expressed in the adult human CNS. Under pathological conditions, phosphorylated tau aggregates are a defining feature of neurodegenerative disorders called tauopathies. Recent findings have suggested a potential role of the gut-brain axis in CNS homeostasis, and therefore we set out to examine the isoform profile and phosphorylation state of tau in the enteric nervous system (ENS) under physiological conditions and in tauopathies. Surgical specimens of human colon from controls, Parkinson’s disease (PD) and progressive supranuclear palsy (PSP) patients were analyzed by Western Blot and immunohistochemistry using a panel of anti-tau antibodies. We found that adult human ENS primarily expresses two tau isoforms, localized in the cell bodies and neuronal processes. We did not observe any difference in the enteric tau isoform profile and phosphorylation state between PSP, PD and control subjects. The htau mouse model of tauopathy also expressed two main isoforms of human tau in the ENS, and there were no apparent differences in ENS tau localization or phosphorylation between wild-type and htau mice. Tau in both human and mouse ENS was found to be phosphorylated but poorly susceptible to dephosphorylation with lambda phosphatase. To investigate ENS tau phosphorylation further, primary cultures from rat enteric neurons, which express four isoforms of tau, were pharmacologically manipulated to show that ENS tau phosphorylation state can be regulated, at least in vitro. Our study is the first to characterize tau in the rodent and human ENS. As a whole, our findings provide a basis to unravel the functions of tau in the ENS and to further investigate the possibility of pathological changes in enteric neuropathies and tauopathies.


  • Open Access

    Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways

    by Thomas Wassmer, Lewis Evans, Graham Fraser, James Smith, Michael Perkinton, Andy Billinton, Frederick Livesey

    A current working model is that Alzheimer's disease actively spreads from diseased to healthy neurons, mediated by transfer of extracellular, abnormal, disease-specific forms of the microtubule-associated protein tau. It is currently unclear whether transfer of tau between neurons is a toxic gain-of-function process in dementia, or reflects a constitutive biological process. We report two mechanisms of entry of monomeric tau to neurons: a rapid early dynamin-dependent phase, and a second, slower actin-dependent phase, suggesting that monomeric tau enters neurons via rapid saturable clathrin-mediated endocytosis and also by bulk endocytosis. Aggregated tau entry is independent of actin polymerisation and largely dynamin dependent, consistent with clathrin-mediated endocytosis and distinct from macropinocytosis, the major route for aggregated tau entry reported for non-neuronal cells. Anti-tau antibodies abrogate tau entry into neurons, with tau carrying antibody with it into neurons, indicating that antibody binding is insufficient to prevent neuronal tau entry.


  • Open Access

    Expression of the Neuronal Adaptor Protein X11α Protects Against Memory Dysfunction in a Transgenic Mouse Model of Alzheimer's Disease

    by Jacqueline C. Mitchell, Michael S. Perkinton, Darran M. Yates, Kwok-Fai Lau, Boris Rogelj, Christopher C.J. Miller, Declan M. McLoughlin

    X11α is a neuronal-specific adaptor protein that binds to the amyloid-β protein precursor (AβPP). Overexpression of X11α reduces Aβ production but whether X11α also protects against Aβ-related memory dysfunction is not known. To test this possibility